INNOVATIVE STRATEGIES OF PHARMACEUTICAL COMPANIES AS A FACTOR FOR ECONOMIC AND BUSINESS DEVELOPMENT
Abstract
The pharmaceutical industry creates innovative products and services related to health promotion, disease prevention, diagnosis, treatment and rehabilitation, used for generation of the final output - improvement of the population health status. The new health services or products are type of innovations and they are created for the purpose of solving socially significant problems and to meet the priorities, objectives and innovation strategies for economic growth of the companies. The development of an innovation strategy within a pharmaceutical company is based on forecasts of the economic, research and technical development of the pharmaceutical sector.
References
Vodenicharov, Ts., Innovations in public healthcare, Sofia, 2012
Hristov, S., “Strategic Management”, UNWE, Sofia, 2000
GeorgievmI.,Ts.Tsvetkov,“Managementofcorporateinnovationsandinvestment”,Sofia,1997 4. Zavlin, P., Introduction to innovation management, 2004.
Cooper, R., “Product innovation and technological strategy”, 2000
Achilladelis, В., N. Antonakis, The Dynamics of Technological Innovation: the Case of the Pharmaceutical Industry, Research Policy 30 – 2001
Купър, Р., “ Продуктова иновация и технологична стратегия”, 2000
Views:
89
Downloads:
59
Copyright (c) 2016 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
